Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe COVID-19”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04669015
What this trial is testing

Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19

Who this might be right for
Covid19
Genova Inc. 914
Early research (Phase 1)Study completedNCT04582201
What this trial is testing

A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS

Who this might be right for
Respiratory Distress Syndrome, Adult
MiNK Therapeutics 20
Large-scale testing (Phase 3)UnknownNCT04952805
What this trial is testing

Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.

Who this might be right for
Covid19
Toscana Life Sciences Sviluppo s.r.l. 800
Testing effectiveness (Phase 2)Ended earlyNCT04582318
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19

Who this might be right for
SARS-CoV-2 Infection
NGM Biopharmaceuticals, Inc 16
Post-approval studies (Phase 4)Ended earlyNCT04362332
What this trial is testing

Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19

Who this might be right for
COVID-19
UMC Utrecht 25
Testing effectiveness (Phase 2)Study completedNCT04900337
What this trial is testing

Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.

Who this might be right for
Covid19
Amorphical Ltd. 66
Post-approval studies (Phase 4)Study completedNCT04952857
What this trial is testing

Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease

Who this might be right for
Covid19
Post Graduate Institute of Medical Education and Research, Chandigarh 90
Testing effectiveness (Phase 2)WithdrawnNCT04452097
What this trial is testing

Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS

Who this might be right for
COVID-19ARDSAcute Respiratory Distress Syndrome
Baylx Inc.
Not applicableStudy completedNCT04686760
What this trial is testing

Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients

Who this might be right for
Corona Virus Infection
University of Lahore 278
Testing effectiveness (Phase 2)UnknownNCT04674566
What this trial is testing

Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19

Who this might be right for
Covid19
Corat Therapeutics Gmbh 45
Testing effectiveness (Phase 2)UnknownNCT04521400
What this trial is testing

The Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19

Who this might be right for
Covid19
Shahid Beheshti University of Medical Sciences 100
Large-scale testing (Phase 3)Study completedNCT04501783
What this trial is testing

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
R-Pharm 168
Large-scale testing (Phase 3)WithdrawnNCT04361461
What this trial is testing

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Who this might be right for
Coronavirus InfectionsSARS-CoV 2SARS (Severe Acute Respiratory Syndrome)+1 more
Apsen Farmaceutica S.A.
Large-scale testing (Phase 3)UnknownNCT05675072
What this trial is testing

Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19

Who this might be right for
Mild to Moderate COVID-19
Frontier Biotechnologies Inc. 1,336
Very early researchTemporarily pausedNCT04329572
What this trial is testing

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19
Azidus Brasil 400
Testing effectiveness (Phase 2)Study completedNCT04701658
What this trial is testing

A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
Eli Lilly and Company 109
Large-scale testing (Phase 3)Ended earlyNCT05279235
What this trial is testing

Efficacy and Safety of JT001 (VV116) Compared With Favipiravir

Who this might be right for
Moderate to Severe COVID-19
Shanghai Vinnerna Biosciences Co., Ltd. 290
Not applicableWithdrawnNCT04466657
What this trial is testing

Antioxidant Therapy for COVID-19 Study

Who this might be right for
Covid-19
Obafemi Awolowo University
Not applicableUnknownNCT04429711
What this trial is testing

Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Sheba Medical Center 100
Testing effectiveness (Phase 2)Ended earlyNCT05195749
What this trial is testing

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

Who this might be right for
COVID-19
101 Therapeutics 3
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation